Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pitichai Phornsarayuth"'
Autor:
Anchalee Tantiwetrueangdet, Ravat Panvichian, Sansanee Wongwaisayawan, Pitichai Phornsarayuth, Panuwat Lertsithichai
HER2 amplification/overexpression is the predictive biomarker for HER2-targeted therapy. However, there are technical limitations to HER2 detection by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Recently, novel HER2-dire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b71305cada2d7a8d63f172f687ec2a4
https://doi.org/10.21203/rs.3.rs-2892947/v1
https://doi.org/10.21203/rs.3.rs-2892947/v1
Autor:
Jirawan Panachan, Napat Rojsirikulchai, Nutkridta Pongsakul, Ladawan Khowawisetsut, Pongpak Pongphitcha, Teerapong Siriboonpiputtana, Takol Chareonsirisuthigul, Pitichai Phornsarayuth, Nisakorn Klinkulab, Natini Jinawath, Wararat Chiangjong, Usanarat Anurathapan, Kovit Pattanapanyasat, Suradej Hongeng, Somchai Chutipongtanate
Publikováno v:
Cancers; Volume 14; Issue 11; Pages: 2627
MYCN amplification is the strongest predictor of high-risk neuroblastoma (NB). The standard procedure to detect MYCN status requires invasive procedures. Extracellular vesicles (EVs) contain molecular signatures of originated cells, present in bioflu
Autor:
Jirawan, Panachan, Napat, Rojsirikulchai, Nutkridta, Pongsakul, Ladawan, Khowawisetsut, Pongpak, Pongphitcha, Teerapong, Siriboonpiputtana, Takol, Chareonsirisuthigul, Pitichai, Phornsarayuth, Nisakorn, Klinkulab, Natini, Jinawath, Wararat, Chiangjong, Usanarat, Anurathapan, Kovit, Pattanapanyasat, Suradej, Hongeng, Somchai, Chutipongtanate
Publikováno v:
Cancers. 14(11)
Autor:
Lucksamee Malee, Pitichai Phornsarayuth, Veerawat Korkiatsakul, Budsaba Rerkamnuaychoke, Takol Chareonsirisuthigul
3, 8, Thai Journal of Genetics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::634c25f63e2d93d3be8e6a8673b798ca